Compare HCA Health Inc (HCA) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Kimberly Clark Corp — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Kimberly Clark Corp trades at $97.57 (market cap $32.09B). The key difference: HCA Health Inc is far larger — about 3× Kimberly Clark Corp's market cap, and Kimberly Clark Corp pays the higher dividend (5.31%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Kimberly Clark Corp for 93 Days on average.
| HCA | KMB | |
|---|---|---|
Market Cap | $95.08B | $32.09B |
Volume | 998,787 | 2,800,459 |
Sector | Health | Consumer Staples |
52-Week High | $545.13 | $121.44 |
52-Week Low | $361.32 | $93.05 |
Typical Hold Time | 76 Days | 93 Days |
Enterprise Value | $145.62B | $37.65B |
Dividend Yield | 0.71% | 5.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Kimberly-Clark (KMB) trades at $97.74, up 1.0% on the day, with a bearish technical signal but strong dividend yield of 5.16%. Recent earnings show a mix of beats and a Q2 2026 miss, while the pending Kenvue acquisition and executive transitions dominate news. The stock is undervalued relative to its consensus price target of $117.25, with a P/E of 19.07 and robust profitability metrics including a net income margin of 11.79%.
KMB offers a high dividend yield and valuation upside, but risks include integration challenges from the Kenvue deal, cash flow pressures, and bearish technical trends. Analyst consensus is cautious with 61% hold ratings, reflecting concerns over execution and sustainability of the dividend amid acquisition-related liabilities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
